Articles

MDoutlookĀ® Delivers Precision Intelligence

MDoutlook empowers confident business decisions with valuable precision insights and actionable intelligence. At the recent 2019 annual meeting of the Association of Residents in Radiation Oncology (ASTRO), one of our clients was interested in recruiting very specific radiation oncologists (recruited to a very tight inclusion criteria) to an event at
Read more
ImmunoOncology (IO) expands the treatment possibilities and provides substantial clinical benefit, especially in patients who had little to no effective treatment options less than a decade ago. IO features prominently at the 2019 annual European Society for Medical Oncology (ESMO) annual congress in Barcelona where agenda items will cover topics
Read more
In todayā€™s climate, the imperative for new products or brands to achieve their full potential quickly has never been greater. Key to achieving success is measuring and communicating progress, both internally and externally. Tracking your product is an iterative process of measuring, managing and monitoring key performance indicators (KPIs) for
Read more
Increasingly, biopharmaceutical companies recognize the importance and value of identifying and engaging ā€˜rising starsā€™ since they are typically younger, tech-engaged, offer novel perspectives, future ThoughtLeaders and a window to tomorrowā€™s healthcare market. Similarly, clients are increasingly using MDoutlook precision intelligence to identify the most relevant rising star ThoughtLeaders (TL; also
Read more
After every major conference, MDoutlook provides valuable insights on the impact of new data presented. In our 3rd OncoPollā„¢ study following the 2019 ASCO conference, we looked at the oral presentations in CLL and researched how US and EU5 oncologists evaluated them. Even with these CLL presentations being on the
Read more
After every major conference, MDoutlook provides valuable insights on the impact of new data presented. In our 2nd OncoPollā„¢ study following the 2019 ASCO conference, we researched what US and EU5 oncologists thought about a number of new agents being developed that target specific driver mutations in small populations of
Read more
After every major conference, MDoutlook provides valuable insights on the impact of new data presented. At the 2019 ASCO conference, prostate cancer was one of the hottest areas, and our 1st independent OncoPollā„¢ study researched how clinicians will be treating the non-metastatic castration-resistant and the metastatic hormone-sensitive prostate cancer (nmCRPC
Read more
Identifying the right expert at the right time is often a challenge for many life sciences companies and their agencies. What if there would be a short-cut (with no compromises!) to gain precision engagement with ThoughtLeaders and related treaters? At MDoutlook, we help you tap into the expertise of over
Read more
With the deluge of scientific data presentations at a conference, it is very competitive for life science companies to break through the noise and assess impact. By evaluating whether announcements change oncologistsā€™ behavior, we can estimate how a data presentation influences their future treatment decisions and clinical practice. Clients often
Read more
MDoutlook empowers confident business decisions with valuable precision insights and actionable intelligence. At the recent 2019 annual meeting of the Association of Residents in Radiation Oncology (ASTRO), one of our clients was interested in recruiting very specific radiation oncologists (recruited to a very tight inclusion criteria) to an event at
Read more
ImmunoOncology (IO) expands the treatment possibilities and provides substantial clinical benefit, especially in patients who had little to no effective treatment options less than a decade ago. IO features prominently at the 2019 annual European Society for Medical Oncology (ESMO) annual congress in Barcelona where agenda items will cover topics
Read more
In todayā€™s climate, the imperative for new products or brands to achieve their full potential quickly has never been greater. Key to achieving success is measuring and communicating progress, both internally and externally. Tracking your product is an iterative process of measuring, managing and monitoring key performance indicators (KPIs) for
Read more
Increasingly, biopharmaceutical companies recognize the importance and value of identifying and engaging ā€˜rising starsā€™ since they are typically younger, tech-engaged, offer novel perspectives, future ThoughtLeaders and a window to tomorrowā€™s healthcare market. Similarly, clients are increasingly using MDoutlook precision intelligence to identify the most relevant rising star ThoughtLeaders (TL; also
Read more
After every major conference, MDoutlook provides valuable insights on the impact of new data presented. In our 3rd OncoPollā„¢ study following the 2019 ASCO conference, we looked at the oral presentations in CLL and researched how US and EU5 oncologists evaluated them. Even with these CLL presentations being on the
Read more
After every major conference, MDoutlook provides valuable insights on the impact of new data presented. In our 2nd OncoPollā„¢ study following the 2019 ASCO conference, we researched what US and EU5 oncologists thought about a number of new agents being developed that target specific driver mutations in small populations of
Read more
After every major conference, MDoutlook provides valuable insights on the impact of new data presented. At the 2019 ASCO conference, prostate cancer was one of the hottest areas, and our 1st independent OncoPollā„¢ study researched how clinicians will be treating the non-metastatic castration-resistant and the metastatic hormone-sensitive prostate cancer (nmCRPC
Read more
Identifying the right expert at the right time is often a challenge for many life sciences companies and their agencies. What if there would be a short-cut (with no compromises!) to gain precision engagement with ThoughtLeaders and related treaters? At MDoutlook, we help you tap into the expertise of over
Read more
With the deluge of scientific data presentations at a conference, it is very competitive for life science companies to break through the noise and assess impact. By evaluating whether announcements change oncologistsā€™ behavior, we can estimate how a data presentation influences their future treatment decisions and clinical practice. Clients often
Read more
MDoutlook empowers confident business decisions with valuable precision insights and actionable intelligence. At the recent 2019 annual meeting of the Association of Residents in Radiation Oncology (ASTRO), one of our clients was interested in recruiting very specific radiation oncologists (recruited to a very tight inclusion criteria) to an event at
Read more
ImmunoOncology (IO) expands the treatment possibilities and provides substantial clinical benefit, especially in patients who had little to no effective treatment options less than a decade ago. IO features prominently at the 2019 annual European Society for Medical Oncology (ESMO) annual congress in Barcelona where agenda items will cover topics
Read more
In todayā€™s climate, the imperative for new products or brands to achieve their full potential quickly has never been greater. Key to achieving success is measuring and communicating progress, both internally and externally. Tracking your product is an iterative process of measuring, managing and monitoring key performance indicators (KPIs) for
Read more
Increasingly, biopharmaceutical companies recognize the importance and value of identifying and engaging ā€˜rising starsā€™ since they are typically younger, tech-engaged, offer novel perspectives, future ThoughtLeaders and a window to tomorrowā€™s healthcare market. Similarly, clients are increasingly using MDoutlook precision intelligence to identify the most relevant rising star ThoughtLeaders (TL; also
Read more
After every major conference, MDoutlook provides valuable insights on the impact of new data presented. In our 3rd OncoPollā„¢ study following the 2019 ASCO conference, we looked at the oral presentations in CLL and researched how US and EU5 oncologists evaluated them. Even with these CLL presentations being on the
Read more
After every major conference, MDoutlook provides valuable insights on the impact of new data presented. In our 2nd OncoPollā„¢ study following the 2019 ASCO conference, we researched what US and EU5 oncologists thought about a number of new agents being developed that target specific driver mutations in small populations of
Read more
After every major conference, MDoutlook provides valuable insights on the impact of new data presented. At the 2019 ASCO conference, prostate cancer was one of the hottest areas, and our 1st independent OncoPollā„¢ study researched how clinicians will be treating the non-metastatic castration-resistant and the metastatic hormone-sensitive prostate cancer (nmCRPC
Read more
Identifying the right expert at the right time is often a challenge for many life sciences companies and their agencies. What if there would be a short-cut (with no compromises!) to gain precision engagement with ThoughtLeaders and related treaters? At MDoutlook, we help you tap into the expertise of over
Read more
With the deluge of scientific data presentations at a conference, it is very competitive for life science companies to break through the noise and assess impact. By evaluating whether announcements change oncologistsā€™ behavior, we can estimate how a data presentation influences their future treatment decisions and clinical practice. Clients often
Read more
Three Ways to Identify and Activate ThoughtLeaders

3 Ways To Identify And Activate ThoughtLeaders Webinar

In this webinar, we will help you (1) go deeper in identifying your ThoughtLeaders in a specific disease area, (2) to target your ThoughtLeaders for the right type of activity and (3) provide you the foundation for building stronger relationships with specific ThoughtLeaders and their influence networks.

Read More Ā»
Webinar Cover

Performance Tracking To Stay Ahead Of The Curve Webinar

You need brand and market insights yesterday! You are not satisfied with the insights provided because each time you receive them, they are out of date. You want to stay one step ahead. In this webinar, we share ways that you can stay ahead by reacting in time through informed confident business decisions.

Read More Ā»